ALLMEDTECH.COM
ALLMEDTECH.COM
MEDICAL, SURGICAL, DENTAL,
PHARMACEUTICALS , OBGYN,
VETERINARY & PET SUPPLIES,
DIAGNOSTIC LAB, COSMETICS,
VACCINES , INJECTABLES , IV ,
GENERIC & OTC MEDICATIONS ,
PHARMACY'S AND MED-SPORT
SUPPLIES & EQUIPMENTS
TOLL FREE: 1-800-939-6944
Afluria
Quadrivalent 2020 - 2021 Pediatric Flu Vaccine
30 mcg / 0.25 mL Indicated
For People 6 Months to 35 Months of Age
Prefilled Syringe 0.25 mL
Seqirus 33332022020
Quadrivalent 2020 - 2021 Pediatric Flu Vaccine
30 mcg / 0.25 mL Indicated
For People 6 Months to 35 Months of Age
Prefilled Syringe 0.25 mL
Seqirus 33332022020
Product Description
Afluria
Quadrivalent 2020 - 2021 Pediatric Flu Vaccine
30 mcg / 0.25 mL Indicated
For People 6 Months to 35 Months of Age
Prefilled Syringe 0.25 mL
Seqirus 33332022020
Features AFLURIA® QUADRIVALENT is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine 5 mL multi-dose vial ( for persons 6 months of age and older). AFLURIA QUADRIVALENT is a sterile suspension for intramuscular injection AFLURIA QUADRIVALENT is standardized according to USPHS requirements for the 2020 - 2021 influenza season and is formulated to contain 60 mcg hemagglutinin (HA) per 0.5 mL dose in the recommended ratio of 15 mcg HA for each of the four influenza strains recommended for the 2020 - 2021 Northern Hemisphere influenza season:
Quadrivalent 2020 - 2021 Pediatric Flu Vaccine
30 mcg / 0.25 mL Indicated
For People 6 Months to 35 Months of Age
Prefilled Syringe 0.25 mL
Seqirus 33332022020
Features AFLURIA® QUADRIVALENT is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine 5 mL multi-dose vial ( for persons 6 months of age and older). AFLURIA QUADRIVALENT is a sterile suspension for intramuscular injection AFLURIA QUADRIVALENT is standardized according to USPHS requirements for the 2020 - 2021 influenza season and is formulated to contain 60 mcg hemagglutinin (HA) per 0.5 mL dose in the recommended ratio of 15 mcg HA for each of the four influenza strains recommended for the 2020 - 2021 Northern Hemisphere influenza season: